Re: Almost 1.25 years now

No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Almost 1.25 years now

in response to

Re: Almost 1.25 years now

Toinv

posted on May 31, 2018 04:29PM

The way I see it , if Zenith signs any type of deal with a BP, i think RVX will jump up based the fact that now BP is very interested in an Epigentic platfom.

Other epigenetics biotech have partnered with other BP so why not Zenith, assuming good results come form Zen 3694

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply